Earl Martin Douglas, General Counsel at BIOMIMETIC THERAPEUTICS, INC. (BMTI), sold 9,000 shares at $3.06 ($27K) on 2011-10-14, disclosed to the SEC on 2011-10-14.
Scheduled sale ($27k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 3,000 | $9K | 33.1% |
| 2 | $2.98 | 3,000 | $9K | 33.0% |
| 3 | $3.06 | 3,000 | $9K | 33.9% |
| Total | $3.01 avg | 9,000 | $27K | 100% |
| Filing → |
| ALLO | SELL | 2025-02-05 | $11K | — | Filing → |
| BMTI | SELL | 2012-03-28 | $126K | — | Filing → |
| BMTI | SELL | 2011-10-11 | $36K | — | Filing → |